These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33242359)

  • 1. Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy.
    Miwa T; Hanai T; Toshihide M; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
    Hepatol Res; 2021 Jun; 51(6):662-673. PubMed ID: 33242359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study.
    Miwa T; Hanai T; Hirata S; Nishimura K; Sahashi Y; Unome S; Imai K; Shirakami Y; Suetsugu A; Takai K; Shimizu M
    Clin Nutr ESPEN; 2024 Oct; 63():267-273. PubMed ID: 38972037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.
    Yoshimura E; Ichikawa T; Miyaaki H; Taura N; Miuma S; Shibata H; Honda T; Takeshima F; Nakao K
    Biomed Rep; 2016 Aug; 5(2):193-198. PubMed ID: 27446540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M
    JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy.
    Hanai T; Shiraki M; Nishimura K; Miwa T; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shimizu M
    Hepatol Commun; 2021 Sep; 5(9):1518-1526. PubMed ID: 34510827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.
    Barone M; Shahini E; Iannone A; Viggiani MT; Corvace V; Principi M; Di Leo A
    Dig Liver Dis; 2018 May; 50(5):496-500. PubMed ID: 29530628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
    Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
    Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.
    Taneja S; Dhiman RK; Khatri A; Goyal S; Thumbru KK; Agarwal R; Duseja A; Chawla Y
    J Clin Exp Hepatol; 2012 Dec; 2(4):306-14. PubMed ID: 25755452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.
    He Q; Mao C; Chen Z; Zeng Y; Deng Y; Hu R
    Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
    Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
    Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.
    Lauridsen MM; Jepsen P; Wernberg CW; Schaffalitzky de Muckadell OB; Bajaj JS; Vilstrup H
    Hepatol Commun; 2020 Sep; 4(9):1353-1361. PubMed ID: 32923838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Grande L; Camacho I
    Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.
    Hanai T; Shiraki M; Watanabe S; Kochi T; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    Hepatol Res; 2017 Dec; 47(13):1359-1367. PubMed ID: 28199774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.